
    
      To determine the pharmacokinetic profile and peak bupivacaine plasma concentration with the
      use of an Exparel/bupivacaine mixture in children ages two through seventeen. We will be
      collecting blood samples at different times during 96 hours or until the patient is
      discharged from the hospital. There will be two different groups participating in the study
      alternating the times in which the blood samples will be collected. We hypothesize that peak
      plasma concentration will be significantly less than the toxic plasma concentration.
    
  